Summary of clinical data for cases one to nine
| Case | Age | Sex | Clinical features | Duration (days) | Anti-GQ1b titre | SFEMG jitter (μs) | MRI features | Follow up | Final diagnosis |
|---|---|---|---|---|---|---|---|---|---|
| AO, Acute ophthalmoparesis; F, female; M, male; MRI, magnetic resonance imaging; R, right; L, left; SFEMG, single fibre electromyography. | |||||||||
| 1 | 49 | M | Reduced eye movements, hyporeflexia, ataxia, dysarthria | 1 | 28080 (initial) 1706 (repeat) | 45.2 (initial) 22.6 (repeat) | Unremarkable | Complete recovery | MFS |
| 2 | 45 | M | R III palsy, pupil spared | 2 | 1828 (initial) 17 (repeat) | 68.5 (initial) 21.5 (repeat) | R III nerve enhancement | Complete recovery | AO |
| 3 | 61 | M | Reduced eye movements | 7 | 23520 | 39.7 (initial) 21.6 (repeat) | Ischaemic changes | Complete recovery | AO |
| 4 | 54 | M | Reduced eye movements, ataxia | 14 | 30144 | 34.5 (initial) 18.4 (repeat) | Unremarkable | Complete recovery | AO |
| 5 | 52 | F | R III palsy, pupil spared, diabetic | 7 | 66 | 17.7 (mean) | Unremarkable | Complete recovery | Diabetic III palsy |
| 6 | 21 | F | R III palsy, pupil spared | 7 | 50.5 | 22.9 (mean) | Unremarkable | Complete recovery | Idiopathic III palsy |
| 7 | 40 | M | L III palsy, pupil spared, bilateral ptosis | 7 | 62 | 84.3 (mean) | Unremarkable | Improved with pyridostigmine | Ocular myasthenia |
| 8 | 45 | F | Reduced eye movements in all directions | 10 | 58 | 57.1 (mean) | Unremarkable | Improved with pyridostigmine | Ocular myasthenia |
| 9 | 56 | M | R III palsy, ptosis, pupil spared | 14 | 25.5 | 22.6 (mean) | Thickened R cavernous sinus and dura along floor of middle cranial fossa | Improved with oral prednisolone 20 mg for 2 weeks | Tolosa-Hunt syndrome |